Titan Biotech has announced its maiden 1:4 bonus issue, with one share to be issued for every four held, subject to shareholder approval. The multibagger stock has gained over 200% in a year and 100% in 2026. Here’s what investors need to know about the bonus issue and eligibility.
Market Samachar is a news aggregator. This article was originally published by Stocks-Markets-Economic Times. Tap the button above to read the full story on their site.